130 related articles for article (PubMed ID: 38153317)
1. Comparison between whole-body magnetic resonance imaging and whole-body metaiodobenzylguanidine scintigraphy in the evaluation of primary tumor and metastases in neuroblastoma.
Rodrigues MMC; Lederman HM; Grossman I; Castiglioni MLV; Marchetti R; Grass DC; Luisi FAV; Caran EMM
Pediatr Blood Cancer; 2024 Mar; 71(3):e30820. PubMed ID: 38153317
[TBL] [Abstract][Full Text] [Related]
2. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
[TBL] [Abstract][Full Text] [Related]
3. Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods.
Goo HW; Choi SH; Ghim T; Moon HN; Seo JJ
Pediatr Radiol; 2005 Aug; 35(8):766-73. PubMed ID: 15864576
[TBL] [Abstract][Full Text] [Related]
4. Prospective observational study on diagnostic accuracy of whole-body MRI in solid small round cell tumours.
Kembhavi SA; Rangarajan V; Shah S; Qureshi S; Arora B; Juvekar S; Laskar S; Vora T; Chinnaswamy G; Ramadwar M; Kurkure P
Clin Radiol; 2014 Sep; 69(9):900-8. PubMed ID: 24863003
[TBL] [Abstract][Full Text] [Related]
5. Integrated imaging using MRI and 123I metaiodobenzylguanidine scintigraphy to improve sensitivity and specificity in the diagnosis of pediatric neuroblastoma.
Pfluger T; Schmied C; Porn U; Leinsinger G; Vollmar C; Dresel S; Schmid I; Hahn K
AJR Am J Roentgenol; 2003 Oct; 181(4):1115-24. PubMed ID: 14500242
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
7.
Gassenmaier S; Bares R; Barreuther M; Flaadt T; Lang P; Schaefer JF; Tsiflikas I
Pediatr Radiol; 2021 Jun; 51(7):1223-1230. PubMed ID: 33544193
[TBL] [Abstract][Full Text] [Related]
8. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
Dhull VS; Sharma P; Patel C; Kundu P; Agarwala S; Bakhshi S; Bhatnagar V; Bal C; Kumar R
Nucl Med Commun; 2015 Oct; 36(10):1007-13. PubMed ID: 26049371
[TBL] [Abstract][Full Text] [Related]
10. [Metaiodobenzylguanidine scintigraphy in the diagnosis and followup of neuroblastoma. Apropos of 16 cases].
Hammami H; Hassine L; Mhiri A; Sellem A; Oubich F; Gharssallah L; Barsaoui S; Ben Brahim H
Tunis Med; 2007 May; 85(5):413-6. PubMed ID: 17657930
[TBL] [Abstract][Full Text] [Related]
11. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
Kroiss A; Putzer D; Uprimny C; Decristoforo C; Gabriel M; Santner W; Kranewitter C; Warwitz B; Waitz D; Kendler D; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2011 May; 38(5):865-73. PubMed ID: 21279352
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma.
Perel Y; Conway J; Kletzel M; Goldman J; Weiss S; Feyler A; Cohn SL
J Pediatr Hematol Oncol; 1999; 21(1):13-8. PubMed ID: 10029806
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of whole-body MRI in Opsoclonus-myoclonus syndrome: a clinical case series (3 case reports).
Storz C; Bares R; Ebinger M; Handgretinger R; Tsiflikas I; Schäfer JF
BMC Med Imaging; 2019 Aug; 19(1):70. PubMed ID: 31429709
[TBL] [Abstract][Full Text] [Related]
14. I-131 MIBG post-therapy scan is more sensitive than I-123 MIBG pretherapy scan in the evaluation of metastatic neuroblastoma.
Yang J; Codreanu I; Servaes S; Zhuang H
Nucl Med Commun; 2012 Nov; 33(11):1134-7. PubMed ID: 22825037
[TBL] [Abstract][Full Text] [Related]
15. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
El-Maghraby T
Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the utility of
Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
[TBL] [Abstract][Full Text] [Related]
17. Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review.
Kalus S; Saifuddin A
Eur Radiol; 2019 Oct; 29(10):5700-5708. PubMed ID: 30915559
[TBL] [Abstract][Full Text] [Related]
18. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
Burak Z; Yüksel DA; Cetingül N; Kantar M; Ozkiliç H; Moretti JL
Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908
[TBL] [Abstract][Full Text] [Related]
19. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
Lumbroso J; Guermazi F; Hartmann O; Coornaert S; Rabarison Y; Lemerle J; Parmentier C
Bull Cancer; 1988; 75(1):97-106. PubMed ID: 3359060
[TBL] [Abstract][Full Text] [Related]
20. Iodine-123 metaiodobenzylguanidine scintigraphy scoring allows prediction of outcome in patients with stage 4 neuroblastoma: results of the Cologne interscore comparison study.
Decarolis B; Schneider C; Hero B; Simon T; Volland R; Roels F; Dietlein M; Berthold F; Schmidt M
J Clin Oncol; 2013 Mar; 31(7):944-51. PubMed ID: 23341514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
